AEB 0.00% 0.9¢ affinity energy and health limited

AEB,doing nice:) CAN have the bigger clout,,,IMHO,,and the...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 7,611 Posts.
    lightbulb Created with Sketch. 28
    AEB,doing nice

    CAN have the bigger clout,,,IMHO,,and the others will catch up,Good to see QBL
    go from just food bling to med tech,THC close on the heals,and a plethora of other
    smoldering just fine.....and the rest one will not list as you now doubt know them all.

    About the world,treated this as one of creations best all round gifts,
    instead of putting hundreds of thousand into servatute,for nothing,
    fueling,prices stock of those who manage incarceration,instead of
    funneling such funds to the truly needy.

    Anyway,since this topic is general,IMHO,CAN
    is run by boffins and egg heads,and with people with savvy...

    Loved their IPO,,sitting,,,yum yum...sitting and grinning.

    And to think that a while ago it was so down ramped,in a post one has long
    ignored,after getting in a while ago.

    And AEB has expanding land availability and Bio tech nouse, in the region most tolerant of this medicine, who's "gov" realized early on,if you cant "fight them join then",and direct
    wasted funds to more beneficial nation building projects.

    The 'sheit"as 'they' say has hit the spinner...even in japan...
    https://www.japantimes.co.jp/news/2...g-become-major-cannabis-supplier-oks-exports/

    and local,will not post all links.
    https://www.sbs.com.au/news/austral...p-medicinal-cannabis-supplier-health-minister


    Any way...DYOR and all that jazz
    Regards
    NoBoDe.
 
watchlist Created with Sketch. Add AEB (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.